These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9531598)

  • 21. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
    Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
    Kater AP; Dicker F; Mangiola M; Welsh K; Houghten R; Ostresh J; Nefzi A; Reed JC; Pinilla C; Kipps TJ
    Blood; 2005 Sep; 106(5):1742-8. PubMed ID: 15914559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
    Chu P; Wierda WG; Kipps TJ
    Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
    Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
    J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
    Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
    Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma.
    Kim LH; Eow GI; Peh SC; Poppema S
    Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands.
    Laytragoon-Lewin N
    Med Oncol; 1998 Apr; 15(1):15-9. PubMed ID: 9643525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.
    Cleary AM; Fortune SM; Yellin MJ; Chess L; Lederman S
    J Immunol; 1995 Oct; 155(7):3329-37. PubMed ID: 7561026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
    Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
    Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells.
    Kim D; Hur DY; Kim YS; Lee K; Lee Y; Cho D; Kang JS; Kim YI; Hahm E; Yang Y; Yoon S; Kim S; Lee WB; Park HY; Kim YB; Hwang YI; Chang KY; Lee WJ
    Hum Immunol; 2002 Jul; 63(7):576-87. PubMed ID: 12072193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis.
    Jakobson E; Jönsson G; Björck P; Paulie S
    Int J Cancer; 1998 Sep; 77(6):849-53. PubMed ID: 9714053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
    Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
    Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.
    Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A
    Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
    Dicker F; Kater AP; Fukuda T; Kipps TJ
    Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
    Lee JR; Koretzky GA
    J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
    Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation.
    Nakanishi K; Matsui K; Kashiwamura S; Nishioka Y; Nomura J; Nishimura Y; Sakaguchi N; Yonehara S; Higashino K; Shinka S
    Int Immunol; 1996 May; 8(5):791-8. PubMed ID: 8671668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unbalanced expression of Fas and CD40 in mantle cell lymphoma.
    Clodi K; Snell V; Zhao S; Cabanillas F; Andreeff M; Younes A
    Br J Haematol; 1998 Oct; 103(1):217-9. PubMed ID: 9792311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.